Mistaken fear of measles shot has ‘devastating’ effect

 

Rochester, Minnesota, USA (August 30, 2011) – More than 150 cases of measles have been reported in the United States already this year and there have been similar outbreaks in Europe, a sign the disease is making an alarming comeback. The reappearance of the potentially deadly virus is the result of unfounded fears about a link between the measles shot and autism that have turned some parents against childhood vaccination, says Gregory Poland, M.D. (http://www.mayoclinic.org/bio/10966366.html), of Mayo Clinic. In the September issue of Mayo Clinic Proceedings (http://www.mayoclinicproceedings.com), Dr. Poland urges doctors to review extensive scientific research that has found no connection between the measles-mumps-rubella (MMR) vaccine and autism.

 

Fears about the MMR vaccine were sparked in 1998 by researcher Andrew Wakefield, M.D., in the British medical journal The Lancet (http://www.sciencedirect.com/science/journal/01406736). Dr. Wakefield’s study was later found fraudulent by the British General Medical Council and the paper was retracted. Even so, suspicions about the vaccine — as well as its additives such as thimerosal — have persisted, gaining steam with the public through celebrity advocates and widespread media coverage.

 

"A rising portion of the population is deciding not to immunize their children because of this controversy, and these children are now susceptible to the measles (http://www.mayoclinic.com/health/measles/DS00331) virus," says Dr. Poland, Mary Lowell Leary Professor of Medicine and director of the Mayo Clinic Vaccine Research Group.

 

"The results have been devastating," Dr. Poland says. "The campaign against the vaccine has caused great harm to public health across multiple nations, even though it has no scientific basis. There have been over 20 studies, spanning two decades, conducted in several countries. Not one has found scientific evidence of a connection between autism spectrum disorders and MMR vaccine."

 

Measles remains the most contagious infectious disease humans can get. It kills roughly three of every thousand people infected. Due to the vaccine’s effectiveness and successful immunization programs worldwide, indigenous cases of the disease had been eliminated in the U.S. and on track to be eradicated, similar to smallpox.

 

Dr. Poland recommends that doctors, patients, and the media become educated about the research on the research that already has been conducted and help rectify the misinformation. A major report released by the Institute of Medicine last week supports Dr. Poland’s claims of no connection between the MMR vaccine and autism (http://www.mayoclinic.com/health/autism/DS00348/DSECTION=causes).

 

"Just as significantly," he adds, "we need to direct appropriate and significant funds to determine what’s really causing autism in our children."

 

 

A peer-reviewed journal, Mayo Clinic Proceedings publishes original articles and reviews dealing with clinical and laboratory medicine, clinical research, basic science research and clinical epidemiology. Mayo Clinic Proceedings is published monthly by Mayo Foundation for Medical Education and Research as part of its commitment to the medical education of physicians. The journal has been published for more than 80 years and has a circulation of 130,000 nationally and internationally. Articles are available online at www.mayoclinicproceedings.com

 

 

About Mayo Clinic

 

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit www.mayoclinic.org/about

 


 

Mayo Clinic, 30.08.2011 (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung